Bank of Montreal
CRVS icon

Bank of Montreal’s Corvus Pharmaceuticals CRVS Stock Holding History

Bank of Montreal’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-17
Closed – – 4752
2019
Q2 		$0 Buy
+17
New +$67 ﹤0.01% 4883
2019
Q1 		– Sell
-195
Closed -$1K – 4386
2018
Q4 		$1K Buy
195
+99
+103% +$675 ﹤0.01% 4515
2018
Q3 		$1K Sell
96
-2
-2% -$20 ﹤0.01% 4506
2018
Q2 		$1K Buy
+98
New +$1.09K ﹤0.01% 4507
2017
Q4 		– Sell
-2,329
Closed -$37K – 4186
2017
Q3 		$37K Hold
2,329
– – ﹤0.01% 3340
2017
Q2 		$28K Buy
+2,329
New +$24.9K ﹤0.01% 3405

Other funds holding CRVS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of Montreal's CRVS Position: Q3 2019 in Review

Bank of Montreal sold out of Corvus Pharmaceuticals (CRVS) in Q3 2019, closing a stake of 17 shares.

Bank of Montreal first reported a position in CRVS in Q2 2017 and held it in 6 quarters. The position peaked at $37K in Q3 2017. 35 funds tracked by Wall St. Rank hold CRVS as of Q3 2019.

  • Bank of Montreal reported no remaining Corvus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 17 Corvus Pharmaceuticals shares in Q3 2019.
  • Bank of Montreal first reported a position in Corvus Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Bank of Montreal's Corvus Pharmaceuticals position peaked at $37K in Q3 2017.
  • 35 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.